medigraphic.com
Colegio de Medicina Interna de México.

2024, Number 8

<< Back Next >>

Med Int Mex 2024; 40 (8)

Post-acute COVID-19 syndrome: an avantgarde perspective on the rebound effect of COVID-19 in a notable case in Puerto Rico

Álvarez GJL, Pacheco RÁL, Portela MJA

Language: Spanish
References: 9
Page: 552-557
PDF size: 191.38 Kb.


ABSTRACT

Background: Current international medical guidelines do not establish an adequate way to deal with the negative long-term impact of COVID-19 on multiple organ systems. Beyond the existing pharmacological therapies on the market, it is evident that the management of these patients is currently individualized due to the context and the macroeconomic/social situation of the place where the infection occurs. Similarly, the follow-up of these patients is poor and post-acute COVID-19 syndrome is often undiagnosed.
Clinical case: A 66-year-old female patient who was diagnosed with post-acute COVID-19 syndrome. Despite having died from complications, she was medically and pharmacologically adequately treated.
Conclusions: This paradigm made it possible to recognize the key elements to carry out an accurate diagnosis and a treatment that will allow proper patient management in individuals who had COVID-19 and recur with multisystem conditions. We firmly believe that this case has allowed us to identify the appropriate procedure to treat this syndrome in an adequately resourced US hospital, but also in any other institutions with limited resources, such as those in Latin America due to the simplicity of the method used and the effectiveness of the treatment.


REFERENCES

  1. Ceban F, Ling S, Lui L, Lee Y, et al. Fatigue and cognitiveimpairment in post-COVID-19 syndrome: A systematicreview and meta-analysis. Brain Behav Immunity 2022;101: 93-135. https://doi.org/10.1016/j.bbi.2021.12.020

  2. Copur S, Berkkan M, Basile C, Tuttle K, Kanbay M. PostacuteCOVID-19 syndrome: what do we know? J Nephrol2022; 35 (3): 795-805. https://doi.org/10.1007/s40620-022-01296-y

  3. Montani D, Savale L, Noel N, Meyrignac O, et al. &COMEBAC Study Group. Post-acute COVID-19 syndrome.Eur Resp Rev 2022; 31 (163): 210185. https://doi.org/10.1183/16000617.0185-2021

  4. Nalbandian A, Sehgal K, Gupta A, Madhavan MV, et al.Post-acute COVID-19 syndrome. Nature Med 2021; 27 (4):601-615. https://doi.org/10.1038/s41591-021-01283-z

  5. Raman B, Bluemke DA, Lüscher TF, Neubauer S. Long COVID:post-acute sequelae of COVID-19 with a cardiovascularfocus. Eur Heart J 2022; 43 (11): 1157-1172. https://doi.org/10.1093/eurheartj/ehac031

  6. Song WJ, Hui CKM, Hull JH, Birring SS, et al. ConfrontingCOVID-19-associated cough and the post-COVIDsyndrome: role of viral neurotropism, neuroinflamma-tion, and neuroimmune responses. Lancet Respir Med2021; 9 (5): 533-544. https://doi.org/10.1016/S2213-2600(21)00125-9

  7. Sykes DL, Holdsworth L, Jawad N, Gunasekera P, et al. Post-COVID-19 symptom burden: What is long-COVID and howshould we manage it? Lung 2021; 199 (2): 113-119. https://doi.org/10.1007/s00408-021-00423-z

  8. Szekanecz Z, Vályi-Nagy I. Posztakut COVID-19 szindróma[Post-acute COVID-19 syndrome]. Orvosi hetilap 2021; 162(27): 1067-1078. https://doi.org/10.1556/650.2021.32282

  9. Yong SJ. Long COVID or post-COVID-19 syndrome: putativepathophysiology, risk factors, and treatments. Infect Dis(London, England) 2021; 53 (10): 737-754. https://doi.org/10.1080/23744235.2021.1924397




2020     |     www.medigraphic.com